Minority shareholders can't foil biotech takeover
The minority shareholders of a biotech startup could not proceed with a class action based on an implied private right of action for violations of the Securities Exchange Act's ant…
The minority shareholders of a biotech startup could not proceed with a class action based on an implied private right of action for violations of the Securities Exchange Act's ant…